Apollo Medicine is the official, peer-reviewed publication of Indraprastha Apollo Hospital and has been conceptualized with the idea of providing a platform for researchers as well as clinicians ever since its inception in September 2004. The Journal is published quarterly (March, June, September & December) by Elsevier, a division of Reed-Elsevier (India) Private Limited and is circulated to all major medical institutions in India and subscribers.
The journal accepts original articles on clinical or laboratory research, review articles, case reports, letter to the editor, article related to quality in the health care, journal scan, interesting videos, Debates, Commissioned Articles, Ethics, Medico Legal Cases, Govt National programmes, Proceedings of the Clinical Meeting, Protocols and Clinical Guidelines and interesting case images. Apollo Medicine aims at publishing articles with a special focus on public health in developing countries, which will highlight the common health problems of the region and their possible solutions. We propose to stimulate medical research and support evidence based medical practice in India and our neighboring countries.Contact details for submission
If assistance is required by the authors, please refer to the tutorials for authors and/or customer support that are available on the EES website; you may also contact the Editorial Office. Please do not post, fax or e-mail your manuscripts to the Editorial Office.
Dr. RN Srivastava, Editor-in-Chief, Apollo Medicine
Office of the Deputy Chief Administrator (Academics)
Indraprastha Apollo Hospitals, Sarita Vihar,
New Delhi – 110076. Phone +91 9313460046.
Email: firstname.lastname@example.org; email@example.com
Ethics in publishing
For information on Ethics in publishing and Ethical guidelines for journal publication see http://www.elsevier.com/publishingethics and http://www.elsevier.com/journal-authors/ethics.
Apollo Medicine takes publication ethics very seriously and abides by the best practice guidance of the Committee on Publication Ethics. Apollo Medicine is a member of CrossCheck by CrossRef and iThenticate which is a plagiarism screening service that verifies the originality of content submitted before publication. Authors, researchers and freelancers can also use iThenticate to screen their work before submission by visiting www.ithenticate.com.
Human and animal rights
If the work involves the use of animal or human subjects, the author should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans http://www.wma.net/en/30publications/10policies/b3/index.html; EU Directive 2010/63/EU for animal experiments http://ec.europa.eu/environment/chemicals/lab_animals/legislation_en.htm; Uniform Requirements for manuscripts submitted to Biomedical journals http://www.icmje.org. Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. If there are no conflicts of interest then please state this: 'Conflicts of interest: none'. See also http://www.elsevier.com/conflictsofinterest. Further information and an example of a Conflict of Interest form can be found at: http://help.elsevier.com/app/answers/detail/a_id/286/p/7923.
Submission declaration and verification
Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis or as an electronic preprint, see http://www.elsevier.com/sharingpolicy), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. To verify originality, your article may be checked by the originality detection service CrossCheck http://www.elsevier.com/editors/plagdetect.
All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted.
Changes to authorship
This policy concerns the addition, deletion, or rearrangement of author names in the authorship of accepted manuscripts:
Before the accepted manuscript is published in an online issue: Requests to add or remove an author, or to rearrange the author names, must be sent to the Journal Manager from the corresponding author of the accepted manuscript and must include: (a) the reason the name should be added or removed, or the author names rearranged and (b) written confirmation (e-mail, fax, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed. Requests that are not sent by the corresponding author will be forwarded by the Journal Manager to the corresponding author, who must follow the procedure as described above. Note that: (1) Journal Managers will inform the Journal Editors of any such requests and (2) publication of the accepted manuscript in an online issue is suspended until authorship has been agreed.
After the accepted manuscript is published in an online issue: Any requests to add, delete, or rearrange author names in an article published in an online issue will follow the same policies as noted above and result in a corrigendum.
Randomized controlled trials should be presented according to the CONSORT guidelines. At manuscript submission, authors must provide the CONSORT checklist accompanied by a flow diagram that illustrates the progress of patients through the trial, including recruitment, enrollment, randomization, withdrawal and completion, and a detailed description of the randomization procedure. The CONSORT checklist and template flow diagram can be found on http://www.consort-statement.org.
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (for more information on this and copyright see http://www.elsevier.com/copyright). Acceptance of the agreement will ensure the widest possible dissemination of information. An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.
Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution and for all other derivative works, including compilations and translations (please consult http://www.elsevier.com/permissions). If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases: please consult http://www.elsevier.com/permissions.
You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated.
Funding body agreements and policies
Elsevier has established a number of agreements with funding bodies which allow authors to comply with their funder's open access policies. Some authors may also be reimbursed for associated publication fees. To learn more about existing agreements please visit http://www.elsevier.com/fundingbodies.
Authors can share their research in a variety of different ways and Elsevier has a number of green open access options available. We recommend authors see our green open access page for further information (http://elsevier.com/greenopenaccess). Authors can also self-archive their manuscripts immediately and enable public access from their institution's repository after an embargo period. This is the version that has been accepted for publication and which typically includes author-incorporated changes suggested during submission, peer review and in editor-author communications. Embargo period: For subscription articles, an appropriate amount of time is needed for journals to deliver value to subscribing customers before an article becomes freely available to the public. This is the embargo period and begins from the publication date of the issue your article appears in.
This journal has an embargo period of 12 months.
Language (usage and editing services)
Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service available from Elsevier's WebShop (http://webshop.elsevier.com/languageediting/) or visit our customer support site (http://support.elsevier.com) for more information.
Studies on patients or volunteers require ethics committee approval and informed consent, which should be documented in the paper. Appropriate consents, permissions and releases must be obtained where an author wishes to include case details or other personal information or images of patients and any other individuals in an Elsevier publication. Written consents must be retained by the author and copies of the consents or evidence that such consents have been obtained must be provided to Elsevier on request. For more information, please review the Elsevier Policy on the Use of Images or Personal Information of Patients or other Individuals, http://www.elsevier.com/patient-consent-policy. Unless you have written permission from the patient (or, where applicable, the next of kin), the personal details of any patient included in any part of the article and in any supplementary materials (including all illustrations and videos) must be removed before submission.
Our online submission system guides you stepwise through the process of entering your article details and uploading your files. The system converts your article files to a single PDF file used in the peer-review process. Editable files (e.g., Word, LaTeX) are required to typeset your article for final publication. All correspondence, including notification of the Editor's decision and requests for revision, is sent by e-mail.
The Journal accepts online submissions in electronic format. All new manuscripts must be submitted through Apollo Medicine online and review Website (http://ees.elsevier.com/apme). Authors are requested to submit the text, tables, and figures in electronic form to this address.
Please follow the following steps to submit your manuscript:Open the homepage of the Journal’s website http://ees.elsevier.com/apme
Register yourself for free by clicking on ‘Register’ on the top and create a user profile with a desired username and mandatory details. On submission of the information, you will receive an E-mail confirming your registration along with the password.
Click ‘Log in’ on the main navigation menu at the top of the journal screen to open the login page.
Enter your username and password in the appropriate fi elds (e-mailed to you at the time of egistration).
Click ‘Author Log in’, this takes you to the ‘Author Main Menu’.
Main MenuNote: Please note that the username and password combination required for Elsevier Editorial System (EES) is different from your username and password combination used to ‘Track your paper’ on the Elsevier ‘Authors’ Home’ website. By submitting a manuscript online, the author agrees to the following:
• The work is original and free from plagiarism.
• It has not been submitted for publication/is not under consideration for publication by another Journal.
• All authors are aware of the order of authorship. The submitting author shall be solely responsible in case disputes arise.
• Once published, copyright of manuscript shall stand transferred to the Journal.
• ‘CONFLICT OF INTEREST’ if any, must be explicitly stated at the end of the manuscript.
Submit your article
Please submit your article via http://ees.elsevier.com/apme/.
Manuscripts must conform to the instructions given below:
Type the manuscript (using ‘Times New Roman’ font, size 10) in single space throughout. Please arrange the manuscript as follows: Title page, Abstract, Introduction, Materials and Method, Results, Discussion, and References. Number all pages consecutively, beginning with the title page. Figures and Tables must be referred to in the manuscript. Consult a recent issue of the Journal for details. Only the Title page should bear the names and complete addresses of the author(s). Editorials and review articles are accepted generally by invitation. Note: The authors should submit the contributors/ copyright form with signatures of all the contributors within 2 weeks of submission.
In general, the length of original articles should be between 2000 and 4000 words and not more than 1000 words for case reports unless the topic demands more explanation (in which case word limit can be eased which is subject to the discretion of the editor). Other short submissions (e.g., innovative techniques, communications) need not have an abstract or all the headings of a full article and be limited to about 500 words in length. These may have a short introduction, case description followed by discussion. Please keep the number of illustration and references to minimum for such short submissions. Letters discussing or criticizing material published recently in the Journal, brief presentations of data, or those pertaining to issues of relevance to health policy,practice of medicine, or the like, are welcome. These should not exceed 500 words, 1 table, and 5 references.
Essential title page information
• Title. Concise and informative. Titles are often used in information-retrieval systems. Avoid abbreviations and formulae where possible.
• Author names and affiliations. Please clearly indicate the given name(s) and family name(s) of each author and check that all names are accurately spelled. Present the authors' affiliation addresses (where the actual work was done) below the names. Indicate all affiliations with a lower-case superscript letter immediately after the author's name and in front of the appropriate address. Provide the full postal address of each affiliation, including the country name and, if available, the e-mail address of each author.
• Corresponding author. Clearly indicate who will handle correspondence at all stages of refereeing and publication, also post-publication. Ensure that the e-mail address is given and that contact details are kept up to date by the corresponding author.
• Present/permanent address. If an author has moved since the work described in the article was done, or was visiting at the time, a 'Present address' (or 'Permanent address') may be indicated as a footnote to that author's name. The address at which the author actually did the work must be retained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes.
In animal studies, the title should state the species; all other titles will refer to human studies. State names of authors (including fi rst names), the departments, and the institution where the work was done. The Journal reserves the right to ask for the contribution of each author to an article. A short, running title, not exceeding 40 characters, should be provided. Please provide the name, postal address with PIN code, facsimile number and E-mail address of the author to whom communications and proofs are to be sent. Acknowledgements, if any, may be mentioned on this page.
The abstract should summarize the most important points in the study. Original articles should include a structured abstract of about 250 words under the following headings: Background/Objectives, Methods, Results, and Conclusions (see Ann Intern Med 1990;113:69–76). For case reports, a non structured abstract should be provided with not more than 100 words. References should not be included in abstracts. Less than 10 keywords, not present in the title, to assist indexing, should be typed in alphabetical order below the Abstract; these may be obtained from the Medical Subject Headings (MeSH) database of ‘Pubmed’.
Immediately after the abstract, provide a maximum of 5 keywords, using American spelling and avoiding general and plural terms and multiple concepts (avoid, for example, 'and', 'of'). Be sparing with abbreviations: only abbreviations firmly established in the field may be eligible. These keywords will be used for indexing purposes.
All measurements must be in metric units, preferably with corresponding SI units in parentheses.
Illustrations should be clear enough and of appropriate size (5 inch × 7 inch or larger) for better reproduction. If illustrations are scanned, then they should be scanned at minimum of 300 dpi. Color images must be CMYK. Line art drawing must have a minimum resolution of 1200 dpi. Photographs may be submitted as ‘.jpeg’, or ‘.tiff’ fi les in a zipped folder. In clinical photographs, identity of the subjects should be suitably masked; in case this is not possible, a written permission from the concerned person should accompany the manuscript. Permission to reproduce any borrowed illustration must be obtained from the author and the publisher.
Please make sure that artwork files are in an acceptable format (TIFF (or JPEG), EPS (or PDF) or MS Office files) and with the correct resolution. If, together with your accepted article, you submit usable color figures then Elsevier will ensure, at no additional charge, that these figures will appear in color online (e.g., ScienceDirect and other sites) in addition to color reproduction in print. For further information on the preparation of electronic artwork, please see http://www.elsevier.com/artworkinstructions.
Legends to Figures
The Figure number (numbered consecutively in Arabic numerals), title and explanations of the Figures should appear in the legend (not on the Figure). Type the legends on a separate page. Enough information should be included in the legend to interpret the Figure without reference to the text.
Each table should be typed on a separate page and numbered consecutively in Arabic numerals. Necessary explanatory notes, if any, may be given below the Table.
Number the references in the order in which they fi rst appear in the text and identify the reference numbers in the text in superscript. References may be placed at the end of the manuscript. Publications as abstract and letters should be so identified in parentheses. The responsibility for accuracy of references lies with the respective authors. The Journal is in agreement with the International Committee of Medical Journal Editors (www.icmje.org). The general arrangement, abbreviations of Journal names and punctuations followed are as per the uniform requirements for manuscripts submitted to Biomedical Journals (www.icmje.org). Please pay attention to the style of references and punctuations as follows:
List all authors when six or less as shown in the example below:
Tallon D, Chard J, Dieppe P. Exploring the priorities of patients with osteoarthritis of the knee. Arthritis Care and Res 2000;13:312–9.When there are seven or more authors, list only the fi rst three and add et al.
Book or monograph
Example: Cassidy JT. Juvenile rheumatoid arthritis. In: Textbook of Rheumatology 6th ed. Kelly, ed. Philadelphia: Saunders 2000:1297–313.
The title of the case that will be discussed in the section “Rare Case Pictures” should be specifi ed. The word limit for summarizing the importance of the image(s) should not exceed 250 words. It is mandatory to mention 2 or 3 learning points. Please limit references to a maximum of 3. Figures/video captions can be uploaded separately.
This section will be available as online image quiz where a brief case report or description will have to be uploaded along with a multiple choice question and a list of possible answers (please limit the answers to a maximum of 6). The correct answer will be displayed with a brief explanation (the answer will also be linked with the published case). The word limit for the description is 250 words, up to 3 references.
These should appear at the end of the manuscript. The source of funding as well as a disclosure statement mentioning confl ict of interest, if any, should appear under this heading.
The following list will be useful during the final checking of an article prior to sending it to the journal for review. Please consult this Guide for Authors for further details of any item.
Ensure that the following items are present:
One author has been designated as the corresponding author with contact details:
• E-mail address
• Full postal address
All necessary files have been uploaded, and contain:
• All figure captions
• All tables (including title, description, footnotes)
• Manuscript has been 'spell-checked' and 'grammar-checked'
• References are in the correct format for this journal
• All references mentioned in the Reference list are cited in the text, and vice versa
• Permission has been obtained for use of copyrighted material from other sources (including the Internet)
Printed version of figures (if applicable) in color or black-and-white
• Indicate clearly whether or not color or black-and-white in print is required.
• For reproduction in black-and-white, please supply black-and-white versions of the figures for printing purposes.
For any further information please visit our customer support site at http://support.elsevier.com.
All articles submitted to the Journal undergo initial review by the Editor/associate editor and articles that are outside the scope of Journal or are not in the journal format are excluded. Later each article is reviewed by at least two reviewers. The time to first decision is usually less than 6 weeks. As per the policy of the Journal, an Editor, who is either author of a manuscript or belongs to the same institution as any of the authors, is not assigned that manuscript and is not involved in decision-making regarding its publication.
Reviewers/Editorial Board members should decline the invitation to review a manuscript which is submitted by authors from their institution. Use of the Digital Object Identifier
The Digital Object Identifier (DOI) may be used to cite and link to electronic documents. The DOI consists of a unique alpha-numeric character string which is assigned to a document by the publisher upon the initial electronic publication. The assigned DOI never changes. Therefore, it is an ideal medium for citing a document, particularly 'Articles in press' because they have not yet received their full bibliographic information. Example of a correctly given DOI (in URL format; here an article in the journal Physics Letters B):
When you use a DOI to create links to documents on the web, the DOIs are guaranteed never to change.
Online proof correction
Corresponding authors will receive an e-mail with a link to our online proofing system, allowing annotation and correction of proofs online. The environment is similar to MS Word: in addition to editing text, you can also comment on figures/tables and answer questions from the Copy Editor. Web-based proofing provides a faster and less error-prone process by allowing you to directly type your corrections, eliminating the potential introduction of errors.
If preferred, you can still choose to annotate and upload your edits on the PDF version. All instructions for proofing will be given in the e-mail we send to authors, including alternative methods to the online version and PDF.
We will do everything possible to get your article published quickly and accurately. Please use this proof only for checking the typesetting, editing, completeness and correctness of the text, tables and figures. Significant changes to the article as accepted for publication will only be considered at this stage with permission from the Editor. It is important to ensure that all corrections are sent back to us in one communication. Please check carefully before replying, as inclusion of any subsequent corrections cannot be guaranteed. Proofreading is solely your responsibility.
We welcome letters to the Editor subject to selection and editing; where appropriate, the authors of the original article will be invited to reply. The letter should be double-spaced throughout, signed by all authors, and fully referenced. The edited version will be returned for approval before publication.
You can track your submitted article at http://www.elsevier.com/track-submission. You can track your accepted article at http://www.elsevier.com/trackarticle. You are also welcome to contact Customer Support via http://support.elsevier.com.